Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.990
+0.040 (2.05%)
At close: Feb 26, 2026, 4:00 PM EST
1.990
0.00 (0.00%)
After-hours: Feb 26, 2026, 5:53 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $186 million as of February 26, 2026. Its market cap has increased by 63.02% in one year.
Market Cap
186.00M
Enterprise Value
47.58M
1-Year Change
63.02%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $186.00M, a decrease of -79.07%. That is a compound annual growth rate of -28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 186.00M | 25.16% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 186.05M |
| NeOnc Technologies Holdings | 185.59M |
| Editas Medicine | 184.50M |
| Karyopharm Therapeutics | 183.99M |
| Tonix Pharmaceuticals Holding | 181.55M |
| Cartesian Therapeutics | 181.51M |
| Eledon Pharmaceuticals | 180.13M |
| SAB Biotherapeutics | 174.72M |